Cargando…

A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport

BACKGROUND: Receptor-mediated transcytosis is one of the major routes for drug delivery of large molecules into the brain. The aim of this study was to develop a novel model of the human blood–brain barrier (BBB) in a high-throughput microfluidic device. This model can be used to assess passage of l...

Descripción completa

Detalles Bibliográficos
Autores principales: Wevers, Nienke R., Kasi, Dhanesh G., Gray, Taylor, Wilschut, Karlijn J., Smith, Benjamin, van Vught, Remko, Shimizu, Fumitaka, Sano, Yasuteru, Kanda, Takashi, Marsh, Graham, Trietsch, Sebastiaan J., Vulto, Paul, Lanz, Henriëtte L., Obermeier, Birgit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117964/
https://www.ncbi.nlm.nih.gov/pubmed/30165870
http://dx.doi.org/10.1186/s12987-018-0108-3
_version_ 1783351848953970688
author Wevers, Nienke R.
Kasi, Dhanesh G.
Gray, Taylor
Wilschut, Karlijn J.
Smith, Benjamin
van Vught, Remko
Shimizu, Fumitaka
Sano, Yasuteru
Kanda, Takashi
Marsh, Graham
Trietsch, Sebastiaan J.
Vulto, Paul
Lanz, Henriëtte L.
Obermeier, Birgit
author_facet Wevers, Nienke R.
Kasi, Dhanesh G.
Gray, Taylor
Wilschut, Karlijn J.
Smith, Benjamin
van Vught, Remko
Shimizu, Fumitaka
Sano, Yasuteru
Kanda, Takashi
Marsh, Graham
Trietsch, Sebastiaan J.
Vulto, Paul
Lanz, Henriëtte L.
Obermeier, Birgit
author_sort Wevers, Nienke R.
collection PubMed
description BACKGROUND: Receptor-mediated transcytosis is one of the major routes for drug delivery of large molecules into the brain. The aim of this study was to develop a novel model of the human blood–brain barrier (BBB) in a high-throughput microfluidic device. This model can be used to assess passage of large biopharmaceuticals, such as therapeutic antibodies, across the BBB. METHODS: The model comprises human cell lines of brain endothelial cells, astrocytes, and pericytes in a two-lane or three-lane microfluidic platform that harbors 96 or 40 chips, respectively, in a 384-well plate format. In each chip, a perfused vessel of brain endothelial cells was grown against an extracellular matrix gel, which was patterned by means of surface tension techniques. Astrocytes and pericytes were added on the other side of the gel to complete the BBB on-a-chip model. Barrier function of the model was studied using fluorescent barrier integrity assays. To test antibody transcytosis, the lumen of the model’s endothelial vessel was perfused with an anti-transferrin receptor antibody or with a control antibody. The levels of antibody that penetrated to the basal compartment were quantified using a mesoscale discovery assay. RESULTS: The perfused BBB on-a-chip model shows presence of adherens and tight junctions and severely limits the passage of a 20 kDa FITC-dextran dye. Penetration of the antibody targeting the human transferrin receptor (MEM-189) was markedly higher than penetration of the control antibody (apparent permeability of 2.9 × 10(−5) versus 1.6 × 10(−5) cm/min, respectively). CONCLUSIONS: We demonstrate successful integration of a human BBB microfluidic model in a high-throughput plate-based format that can be used for drug screening purposes. This in vitro model shows sufficient barrier function to study the passage of large molecules and is sensitive to differences in antibody penetration, which could support discovery and engineering of BBB-shuttle technologies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12987-018-0108-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6117964
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61179642018-09-05 A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport Wevers, Nienke R. Kasi, Dhanesh G. Gray, Taylor Wilschut, Karlijn J. Smith, Benjamin van Vught, Remko Shimizu, Fumitaka Sano, Yasuteru Kanda, Takashi Marsh, Graham Trietsch, Sebastiaan J. Vulto, Paul Lanz, Henriëtte L. Obermeier, Birgit Fluids Barriers CNS Research BACKGROUND: Receptor-mediated transcytosis is one of the major routes for drug delivery of large molecules into the brain. The aim of this study was to develop a novel model of the human blood–brain barrier (BBB) in a high-throughput microfluidic device. This model can be used to assess passage of large biopharmaceuticals, such as therapeutic antibodies, across the BBB. METHODS: The model comprises human cell lines of brain endothelial cells, astrocytes, and pericytes in a two-lane or three-lane microfluidic platform that harbors 96 or 40 chips, respectively, in a 384-well plate format. In each chip, a perfused vessel of brain endothelial cells was grown against an extracellular matrix gel, which was patterned by means of surface tension techniques. Astrocytes and pericytes were added on the other side of the gel to complete the BBB on-a-chip model. Barrier function of the model was studied using fluorescent barrier integrity assays. To test antibody transcytosis, the lumen of the model’s endothelial vessel was perfused with an anti-transferrin receptor antibody or with a control antibody. The levels of antibody that penetrated to the basal compartment were quantified using a mesoscale discovery assay. RESULTS: The perfused BBB on-a-chip model shows presence of adherens and tight junctions and severely limits the passage of a 20 kDa FITC-dextran dye. Penetration of the antibody targeting the human transferrin receptor (MEM-189) was markedly higher than penetration of the control antibody (apparent permeability of 2.9 × 10(−5) versus 1.6 × 10(−5) cm/min, respectively). CONCLUSIONS: We demonstrate successful integration of a human BBB microfluidic model in a high-throughput plate-based format that can be used for drug screening purposes. This in vitro model shows sufficient barrier function to study the passage of large molecules and is sensitive to differences in antibody penetration, which could support discovery and engineering of BBB-shuttle technologies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12987-018-0108-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-31 /pmc/articles/PMC6117964/ /pubmed/30165870 http://dx.doi.org/10.1186/s12987-018-0108-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wevers, Nienke R.
Kasi, Dhanesh G.
Gray, Taylor
Wilschut, Karlijn J.
Smith, Benjamin
van Vught, Remko
Shimizu, Fumitaka
Sano, Yasuteru
Kanda, Takashi
Marsh, Graham
Trietsch, Sebastiaan J.
Vulto, Paul
Lanz, Henriëtte L.
Obermeier, Birgit
A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
title A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
title_full A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
title_fullStr A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
title_full_unstemmed A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
title_short A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
title_sort perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117964/
https://www.ncbi.nlm.nih.gov/pubmed/30165870
http://dx.doi.org/10.1186/s12987-018-0108-3
work_keys_str_mv AT weversnienker aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT kasidhaneshg aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT graytaylor aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT wilschutkarlijnj aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT smithbenjamin aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT vanvughtremko aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT shimizufumitaka aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT sanoyasuteru aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT kandatakashi aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT marshgraham aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT trietschsebastiaanj aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT vultopaul aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT lanzhenriettel aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT obermeierbirgit aperfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT weversnienker perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT kasidhaneshg perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT graytaylor perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT wilschutkarlijnj perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT smithbenjamin perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT vanvughtremko perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT shimizufumitaka perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT sanoyasuteru perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT kandatakashi perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT marshgraham perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT trietschsebastiaanj perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT vultopaul perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT lanzhenriettel perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport
AT obermeierbirgit perfusedhumanbloodbrainbarrieronachipforhighthroughputassessmentofbarrierfunctionandantibodytransport